Kanabo Group PLC (LON:KNB) chief executive Avihu Tamir joins Proactive after passing a significant commercial 'milestone' with the shipment of its first medicinal cannabis cartridges to the UK. They will be sold by the LYPHE Group's clinics and dispensaries to be used with Kanabo’s VapePod device.
This is the first time a medicinal extract formula has been made available for inhalation by a metered-dose medical-grade vaporiser in the UK.
In North America, where the market is more developed than in Europe, vapes make up 20-30% of the market. UK doctors currently prescribe the drug for conditions such as severe epilepsy, multiple sclerosis and pain management.